540 related articles for article (PubMed ID: 16411214)
21. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.
Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA
Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926
[TBL] [Abstract][Full Text] [Related]
23. Mammographic screening for breast cancer in a resource-restricted environment.
Apffelstaedt SP; Dalmayer L; Baatjes K
S Afr Med J; 2014 Apr; 104(4):294-6. PubMed ID: 25118556
[TBL] [Abstract][Full Text] [Related]
24. Age-related differences in patients with nonpalpable breast carcinomas.
Wazer DE; Gage I; Homer MJ; Krosnick SH; Schmid C
Cancer; 1996 Oct; 78(7):1432-7. PubMed ID: 8839548
[TBL] [Abstract][Full Text] [Related]
25. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
26. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
27. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999.
Vacek PM; Geller BM; Weaver DL; Foster RS
Cancer; 2002 Apr; 94(8):2160-8. PubMed ID: 12001112
[TBL] [Abstract][Full Text] [Related]
28. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
Han JS; Molberg KH; Sarode V
Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
[TBL] [Abstract][Full Text] [Related]
29. Performance of digital screening mammography among older women in the United States.
Henderson LM; O'Meara ES; Braithwaite D; Onega T;
Cancer; 2015 May; 121(9):1379-86. PubMed ID: 25537958
[TBL] [Abstract][Full Text] [Related]
30. MRI-guided breast needle core biopsies: pathologic features of newly diagnosed malignancies.
Manion E; Brock JE; Raza S; Reisenbichler ES
Breast J; 2014; 20(5):453-60. PubMed ID: 25040910
[TBL] [Abstract][Full Text] [Related]
31. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Schulz S; Sinn P; Golatta M; Rauch G; Junkermann H; Schuetz F; Sohn C; Heil J
Breast; 2013 Aug; 22(4):537-42. PubMed ID: 23237921
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
[TBL] [Abstract][Full Text] [Related]
33. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.
Dillon MF; Quinn CM; McDermott EW; O'Doherty A; O'Higgins N; Hill AD
J Clin Pathol; 2006 Jul; 59(7):740-3. PubMed ID: 16803949
[TBL] [Abstract][Full Text] [Related]
35. The detection and diagnosis of early, occult and minimal breast cancer.
Hickey RC; Gallager HS; Dodd GD; Samuels BI; Paulus DD; Moore DL
Adv Surg; 1976; 10():287-312. PubMed ID: 185891
[TBL] [Abstract][Full Text] [Related]
36. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
37. Predicting invasion in mammographically detected microcalcification.
Bagnall MJ; Evans AJ; Wilson AR; Pinder SE; Denley H; Geraghty JG; Ellis IO
Clin Radiol; 2001 Oct; 56(10):828-32. PubMed ID: 11895299
[TBL] [Abstract][Full Text] [Related]
38. Lesion Size on Ultrasonography Predicts Potential Invasion in Ductal Carcinoma in situ Preoperatively Diagnosed by Breast Needle Biopsy.
Shimoyama K; Osako T; Mitsuhashi T; Akiyama F; Iwase T
Acta Med Okayama; 2017 Jun; 71(3):233-240. PubMed ID: 28655943
[TBL] [Abstract][Full Text] [Related]
39. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
[TBL] [Abstract][Full Text] [Related]
40. Predicting biopsy outcome after mammography: what is the likelihood the patient has invasive or in situ breast cancer?
Weaver DL; Vacek PM; Skelly JM; Geller BM
Ann Surg Oncol; 2005 Aug; 12(8):660-73. PubMed ID: 15968496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
